Success Of Pfizer Pancreatic Cancer Drug Stops Trial Global drug company Pfizer Inc announced yesterday, 12 March, that a phase 3 clinical trial of its pancreatic cancer drug Sutent (sunitinib malate) stopped early because the drug showed significant benefits in patients. Sutent is designed to treat patients with advanced pancreatic islet cell tumors, also known as pancreatic neuroendocrine tumors.
Source: www.medicalnewstoday.comObesity, Diabetes And Heart Risk Linked To Alzheimer's, Dementia, Cognitive Decline Four studies published in a leading journal this week suggest that metabolic disorders such as obesity and diabetes may share risk factors that affect the development of Alzheimer's disease, other forms of dementia and cognitive decline.
Source: www.medicalnewstoday.comImprovement In Prostate Cancer Care Thanks To Patient Input During Prostate Cancer Awareness month, the University of Leicester reported a recent investigation promising to upgrade prostate cancer care across England. Members from the Department of Health Sciences elaborated a survey system to assist NHS Trusts in improving their services.
Source: www.medicalnewstoday.comRigel Commences Phase 2 Trial Of R788 In Peripheral T-Cell Lymphomas Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) announced the enrollment of the first patient in a Phase 2, multi-center clinical trial of R788 (fostamatinib disodium) in patients with refractory or relapsed peripheral T-cell lymphoma (PTCL). The clinical trial's primary objective is to assess the efficacy of R788, an orally bio-available Syk kinase inhibitor, in patients suffering from this subset of non-Hodgkin's lymphoma that originates in the patient's T-cells.
Source: www.medicalnewstoday.comMontreal Brain Awareness Week Organized By Students From Montreal's 4 Universities Ever wonder what happens when we sleep and dream? As part of Montreal Brain Awareness Week, top neuroscientists will examine those questions during an informal public talk called, Café Scientifique: Sleep and Dreams.
Source: www.medicalnewstoday.comConsuming Too Much Sugar Shortens Lifespan The fact that an animal's lifetime is prolonged by decreasing its sugar ingestion is commonly recognized. In a study published in the journal PLoS Genetics, scientists from the Université de Montréal, reveal that sugar in itself is not the key element but the cells' capacity to detect its presence is. The intricate works of the process of aging are still not clearly defined.
Source: www.medicalnewstoday.comKids Who Live Near Parks Are Physically More Active According to a recent study submitted today at the American Heart Association's conference in Florida, children at risk of being overweight who live in close proximity to parks, green spaces or recreational areas are more physically active. The new ongoing Canadian study is exploring the link between park proximity and walking.
Source: www.medicalnewstoday.comAmpakines Reverse Memory Loss In Animal Model Of Huntington's Disease All neurodegenerative diseases share two characteristics: Prognosis is universally poor, and current treatments work marginally at best. Drug development in this area has focused on neuroprotection and up-regulation of critical neurotransmitters, but to date no experimental treatments have clearly out-shone the standard of care. Now, a study conducted by Prof.
Source: www.medicalnewstoday.comPenn Neuroscientists Find That The Unexpected Is A Key To Human Learning The human brain's sensitivity to unexpected outcomes plays a fundamental role in the ability to adapt and learn new behaviors, according to a new study by a team of psychologists and neuroscientists from the University of Pennsylvania.
Source: www.medicalnewstoday.comLong Term Ozone Exposure Raises The Risk Of Dying From Lung Disease Long-term exposure to elevated levels of ground ozone a major constituent of smog significantly raises the risk of dying from lung disease, according to a new nationwide study of cities that evaluated the impact of ozone on respiratory health over an 18-year period. The study found that the risk of dying from respiratory disease is more than 30 percent greater in metropolitan areas with the highest ozone concentrations than in those with the lowest ozone concentrations.
Source: www.medicalnewstoday.com
# posted by Network @ 11:44 PM
